Literature DB >> 18295055

Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Lesley A Stevens1, Josef Coresh, Christopher H Schmid, Harold I Feldman, Marc Froissart, John Kusek, Jerome Rossert, Frederick Van Lente, Robert D Bruce, Yaping Lucy Zhang, Tom Greene, Andrew S Levey.   

Abstract

BACKGROUND: Serum cystatin C was proposed as a potential replacement for serum creatinine in glomerular filtration rate (GFR) estimation. We report the development and evaluation of GFR-estimating equations using serum cystatin C alone and serum cystatin C, serum creatinine, or both with demographic variables. STUDY
DESIGN: Test of diagnostic accuracy. SETTING & PARTICIPANTS: Participants screened for 3 chronic kidney disease (CKD) studies in the United States (n = 2,980) and a clinical population in Paris, France (n = 438). REFERENCE TEST: Measured GFR (mGFR). INDEX TEST: Estimated GFR using the 4 new equations based on serum cystatin C alone, serum cystatin C, serum creatinine, or both with age, sex, and race. New equations were developed by using linear regression with log GFR as the outcome in two thirds of data from US studies. Internal validation was performed in the remaining one third of data from US CKD studies; external validation was performed in the Paris study. MEASUREMENTS: GFR was measured by using urinary clearance of iodine-125-iothalamate in the US studies and chromium-51-EDTA in the Paris study. Serum cystatin C was measured by using Dade-Behring assay, standardized serum creatinine values were used.
RESULTS: Mean mGFR, serum creatinine, and serum cystatin C values were 48 mL/min/1.73 m(2) (5th to 95th percentile, 15 to 95), 2.1 mg/dL, and 1.8 mg/L, respectively. For the new equations, coefficients for age, sex, and race were significant in the equation with serum cystatin C, but 2- to 4-fold smaller than in the equation with serum creatinine. Measures of performance in new equations were consistent across the development and internal and external validation data sets. Percentages of estimated GFR within 30% of mGFR for equations based on serum cystatin C alone, serum cystatin C, serum creatinine, or both levels with age, sex, and race were 81%, 83%, 85%, and 89%, respectively. The equation using serum cystatin C level alone yields estimates with small biases in age, sex, and race subgroups, which are improved in equations including these variables. LIMITATIONS: Study population composed mainly of patients with CKD.
CONCLUSIONS: Serum cystatin C level alone provides GFR estimates that are nearly as accurate as serum creatinine level adjusted for age, sex, and race, thus providing an alternative GFR estimate that is not linked to muscle mass. An equation including serum cystatin C level in combination with serum creatinine level, age, sex, and race provides the most accurate estimates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295055      PMCID: PMC2390827          DOI: 10.1053/j.ajkd.2007.11.018

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  34 in total

1.  Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients.

Authors:  L Risch; R Herklotz; A Blumberg; A R Huber
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

2.  Chronic kidney disease in the elderly--how to assess risk.

Authors:  Lesley A Stevens; Andrew S Levey
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

3.  Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children.

Authors:  Anders Grubb; Ulf Nyman; Jonas Björk; Veronica Lindström; Bengt Rippe; Gunnar Sterner; Anders Christensson
Journal:  Clin Chem       Date:  2005-06-16       Impact factor: 8.327

4.  Thyroid function differently affects serum cystatin C and creatinine concentrations.

Authors:  L Manetti; E Pardini; M Genovesi; A Campomori; L Grasso; L L Morselli; I Lupi; G Pellegrini; L Bartalena; F Bogazzi; E Martino
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

5.  Kidney function as a predictor of noncardiovascular mortality.

Authors:  Linda F Fried; Ronit Katz; Mark J Sarnak; Michael G Shlipak; Paulo H M Chaves; Nancy Swords Jenny; Catherine Stehman-Breen; Dan Gillen; Anthony J Bleyer; Calvin Hirsch; David Siscovick; Anne B Newman
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

Review 6.  Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.

Authors:  Gary L Myers; W Greg Miller; Josef Coresh; James Fleming; Neil Greenberg; Tom Greene; Thomas Hostetter; Andrew S Levey; Mauro Panteghini; Michael Welch; John H Eckfeldt
Journal:  Clin Chem       Date:  2005-12-06       Impact factor: 8.327

7.  Cystatin C concentration as a risk factor for heart failure in older adults.

Authors:  Mark J Sarnak; Ronit Katz; Catherine O Stehman-Breen; Linda F Fried; Nancy Swords Jenny; Bruce M Psaty; Anne B Newman; David Siscovick; Michael G Shlipak
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

8.  Cystatin C and the risk of death and cardiovascular events among elderly persons.

Authors:  Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

9.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

10.  Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans.

Authors:  P Sjöström; M Tidman; I Jones
Journal:  Scand J Clin Lab Invest       Date:  2005       Impact factor: 1.713

View more
  458 in total

1.  Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States.

Authors:  Deep Sharma; Meredith Hawkins; Matthew K Abramowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 8.237

Review 2.  Genome-wide association studies of chronic kidney disease: what have we learned?

Authors:  Conall M O'Seaghdha; Caroline S Fox
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

3.  Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations.

Authors:  Yuen-Ting Diana Kwong; Lesley A Stevens; Elizabeth Selvin; Yaping Lucy Zhang; Tom Greene; Frederick Van Lente; Andrew S Levey; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2010-07       Impact factor: 8.860

4.  Early renal function decline in type 2 diabetes.

Authors:  Meda E Pavkov; William C Knowler; Kevin V Lemley; Clinton C Mason; Bryan D Myers; Robert G Nelson
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

5.  Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Stacy A Porter; Joseph M Massaro; Udo Hoffmann; Caroline S Fox
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

6.  Vitamin D, parathyroid hormone, and cardiovascular events among older adults.

Authors:  Bryan Kestenbaum; Ronit Katz; Ian de Boer; Andy Hoofnagle; Mark J Sarnak; Michael G Shlipak; Nancy S Jenny; David S Siscovick
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

7.  Chronic kidney disease in octogenarians.

Authors:  Shani Shastri; Hocine Tighiouart; Ronit Katz; Dena E Rifkin; Linda F Fried; Michael G Shlipak; Anne B Newman; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

8.  Insulin resistance and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Kathryn A Britton; Kenneth J Mukamal; Joachim H Ix; David S Siscovick; Anne B Newman; Ian H de Boer; Evan L Thacker; Mary L Biggs; J Michael Gaziano; Luc Djoussé
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

9.  Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.

Authors:  Stella Yi; Elizabeth Selvin; Sabine Rohrmann; Shehzad Basaria; Andy Menke; Nader Rifai; Eliseo Guallar; Elizabeth A Platz; Brad Astor
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

10.  Fibroblast growth factor 23, the ankle-brachial index, and incident peripheral artery disease in the Cardiovascular Health Study.

Authors:  Pranav S Garimella; Joachim H Ix; Ronit Katz; Michel B Chonchol; Bryan R Kestenbaum; Ian H de Boer; David S Siscovick; Shani Shastri; Jade S Hiramoto; Michael G Shlipak; Mark J Sarnak
Journal:  Atherosclerosis       Date:  2014-01-04       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.